Development and validation of convolutional neural network-based model to predict the risk of sentinel or non-sentinel lymph node metastasis in patients with breast cancer: a machine learning study.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: A CNN using learned MRI representations predicted pathology-referenced lymph-node metastasis in the retrospective cohort; second-stage sentinel-dissection input and hypothetical surgery decisions do not demonstrate clinical benefit.
Technology: A convolutional neural network learned MRI representations to predict sentinel and non-sentinel lymph-node metastasis, evaluated against retrospective nodal references.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A convolutional neural network learned MRI representations to predict sentinel and non-sentinel lymph-node metastasis, evaluated against retrospective nodal references.
- Limitation / still unknown
- A CNN using learned MRI representations predicted pathology-referenced lymph-node metastasis in the retrospective cohort; second-stage sentinel-dissection input and hypothetical surgery decisions do not demonstrate clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10474371/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.